| First Author | Emoto T | Year | 2022 |
| Journal | Immunity | Volume | 55 |
| Issue | 5 | Pages | 862-878.e8 |
| PubMed ID | 35508166 | Mgi Jnum | J:324828 |
| Mgi Id | MGI:7281921 | Doi | 10.1016/j.immuni.2022.04.005 |
| Citation | Emoto T, et al. (2022) Colony stimulating factor-1 producing endothelial cells and mesenchymal stromal cells maintain monocytes within a perivascular bone marrow niche. Immunity 55(5):862-878.e8 |
| abstractText | Macrophage colony stimulating factor-1 (CSF-1) plays a critical role in maintaining myeloid lineage cells. However, congenital global deficiency of CSF-1 (Csf1(op/op)) causes severe musculoskeletal defects that may indirectly affect hematopoiesis. Indeed, we show here that osteolineage-derived Csf1 prevented developmental abnormalities but had no effect on monopoiesis in adulthood. However, ubiquitous deletion of Csf1 conditionally in adulthood decreased monocyte survival, differentiation, and migration, independent of its effects on bone development. Bone histology revealed that monocytes reside near sinusoidal endothelial cells (ECs) and leptin receptor (Lepr)-expressing perivascular mesenchymal stromal cells (MSCs). Targeted deletion of Csf1 from sinusoidal ECs selectively reduced Ly6C(-) monocytes, whereas combined depletion of Csf1 from ECs and MSCs further decreased Ly6C(hi) cells. Moreover, EC-derived CSF-1 facilitated recovery of Ly6C(-) monocytes and protected mice from weight loss following induction of polymicrobial sepsis. Thus, monocytes are supported by distinct cellular sources of CSF-1 within a perivascular BM niche. |
